Independent · SA-focused · evidence-led
Weight-loss meds in South Africa,explained honestly
Clear, current information on Ozempic, Wegovy, Mounjaro and Saxenda — prices in Rand, what medical aid covers, side effects, and how to start safely. No hype, no guarantees.
21%
Top average weight loss in trials
4
Main injectable options in SA
15%
Average weight loss on semaglutide
100%
Independent & medically reviewed
Choose a medicationFive ingredients, four main brands in SA
Each guide covers what it is, who it's for, realistic results from the trials, side effects, the price in Rand and medical-aid cover.
Also: semaglutide, tirzepatide & compounded options… See the full category guide
Why this siteA real resource, not a sales page
Most SA pages on these medicines are thin clinic adverts or global content that ignores Rand prices and local medical aids. We do the opposite — balanced, SA-specific, evidence-led.
- Covers Ozempic, Wegovy, Mounjaro & Saxenda
- Risks & side effects, not just benefits
- Cheaper alternatives, explained honestly
- Real Rand prices, reviewed monthly
- Medical-aid cover, scheme by scheme
- When these meds are NOT the answer
Why trust this guideBuilt to a higher standard than the usual clinic blog
Evidence-led
We cite the STEP, SURMOUNT and SURPASS trials and link to primary sources — no outcome guarantees, ever.
SA-specific
Real Rand prices, local pharmacies (Clicks, Dis-Chem, Medirite) and medical aids — not recycled global content.
Medically reviewed
Clinical pages are checked by a registered medical reviewer and date-stamped, so you know what you're reading is current.
How it worksHow to start safely in South Africa
01
Check your eligibility
Use our BMI calculator and eligibility guide to see whether treatment is likely to be appropriate.
02
Consult a registered provider
A doctor assesses your health, history and goals — online or in person — and decides if a medicine is right.
03
Start low, titrate up
If prescribed, you begin a low dose from a licensed pharmacy and step up slowly to limit side effects.
04
Ongoing support & review
Regular follow-ups track progress, manage side effects and keep your plan — and budget — on track.
Next step
Considering a weight-loss medication?
These are prescription-only (Schedule 4) medicines that aren't right for everyone. The responsible next step is a proper assessment with a registered provider, who can start you safely on a genuine product from a licensed pharmacy.
Evidence at a glanceWhat the trials actually found
Semaglutide 2.4 mg produced about 15% average weight loss over 68 weeks in adults without diabetes.
STEP 1 trial
New England Journal of Medicine, 2021Tirzepatide produced up to about 21–22.5% average weight loss at the highest dose over 72 weeks.
SURMOUNT-1 trial
New England Journal of Medicine, 2022Head-to-head, tirzepatide beat semaglutide on weight loss (~20.2% vs 13.7%).
SURMOUNT-5 trial
New England Journal of Medicine, 2025Liraglutide 3.0 mg produced about 8% average weight loss over 56 weeks.
SCALE trial
New England Journal of Medicine, 2015Trial findings are averages alongside diet and lifestyle changes; individual results vary. See our sources.
Go deeperCosts, comparisons & guides
Price guide (Rand)
A maintained table by drug, dose and pharmacy — plus the hidden costs.
See pricesCompare injections
Mounjaro vs Wegovy vs Ozempic vs Saxenda — results, price and availability.
CompareCommon questionsFrequently asked
questions
There's no single “best” — it depends on your goals, budget and health. On average weight loss, Mounjaro (tirzepatide) leads, then Wegovy/Ozempic (semaglutide), then Saxenda. See our comparison.
No. They are Schedule 4 prescription medicines — a registered provider must assess you, and the medicine should be dispensed by a licensed pharmacy.
Roughly R1 900–R5 000+ at maintenance depending on the medicine and dose, before the consultation, blood tests and delivery. See the price guide.
Often not fully — studies show meaningful regain after stopping, which is why these are usually long-term treatments paired with lifestyle change.
About our recommendations